Document resource
Coombes’s report usefully frames the new proposals for medical device regulation from the Medicines and Healthcare Products Regulatory Agency (MHRA) as a patient safety response to a rapidly expanding market in direct-to-consumer self-tests.1 The point that now needs sharper regulatory attention is narrower: when a person buys such a test, the product should make clear who is expected to interpret the result and who carries responsibility for the next step.